Affymetrix Posts Meager Q3 Revenue Growth as Profit Turns to Loss | GenomeWeb
NEW YORK (GenomeWeb News) — Affymetrix today reported that revenue for the third quarter increased around 1 percent as last year's profit swung to a loss.
Total receipts for the three months ended Sept. 30 inched up to $84.6 million from $83.4 million year over year
Affy said $59.8 million in revenue during the period came from GeneChip sales while about $10.1 million was made on reagent revenue and $7.7 million from its genotyping services.  

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.